We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Conformetrix and AstraZeneca Sign Collaborative Agreement

News   Apr 26, 2012

 
Conformetrix and AstraZeneca Sign Collaborative Agreement
 
 
Advertisement
 

RELATED ARTICLES

Fungal Compound Inhibits BMP Receptors

News

Researchers in the group of Jeroen den Hertog, in collaboration with researchers in Leiden, have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins.

READ MORE

Killing Cancer Cells by Blocking Access to the Nucleus

News

Scientists have demonstrated that by blocking the construction of nuclear pore complexes it was possible to shrink aggressive tumors in mice whilst leaving normal cells unaffected.

READ MORE

New Cancer Drug Targeting DNA Repair Shows Promise in Early-Stage Trial

News

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE